233 related articles for article (PubMed ID: 32075384)
1. Immunotherapy-Associated Myocarditis.
Spisarová M
Klin Onkol; 2020; 33(1):20-22. PubMed ID: 32075384
[TBL] [Abstract][Full Text] [Related]
2. Side Effects and Efficacy of Immunotherapy.
Fiala O; Šorejs O; Šustr J; Fínek J
Klin Onkol; 2020; 33(1):8-10. PubMed ID: 32075381
[TBL] [Abstract][Full Text] [Related]
3. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity and Immunotherapy.
Kopecký J
Klin Onkol; 2020; 33(1):11-14. PubMed ID: 32075382
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal Toxicity of Immunotherapy.
Špaček J
Klin Onkol; 2020; 33(1):23-28. PubMed ID: 32075385
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors.
Baik AH; Tsai KK; Oh DY; Aras MA
Clin Sci (Lond); 2021 Mar; 135(5):703-724. PubMed ID: 33686402
[TBL] [Abstract][Full Text] [Related]
7. A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.
Guo CW; Alexander M; Dib Y; Lau PKH; Weppler AM; Au-Yeung G; Lee B; Khoo C; Mooney D; Joshi SB; Creati L; Sandhu S
Eur J Cancer; 2020 Jan; 124():15-24. PubMed ID: 31707280
[TBL] [Abstract][Full Text] [Related]
8. The potential of auto-antigen-guided treatment of immune checkpoint inhibitor-mediated myocarditis.
Zhu H; Huang YV; Wu SM
Med; 2023 Jan; 4(1):13-14. PubMed ID: 36640753
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity.
Zarifa A; Lopez-Mattei J; Palaskas N; Iliescu C; Durand JB; Kim PY
Adv Exp Med Biol; 2020; 1244():277-285. PubMed ID: 32301022
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.
Palaskas N; Lopez-Mattei J; Durand JB; Iliescu C; Deswal A
J Am Heart Assoc; 2020 Jan; 9(2):e013757. PubMed ID: 31960755
[No Abstract] [Full Text] [Related]
11. T cell checkpoint regulators in the heart.
Grabie N; Lichtman AH; Padera R
Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy for Bladder Cancer].
Büchler T
Klin Onkol; 2017; 30(Supplementum3):6-9. PubMed ID: 29239187
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
[TBL] [Abstract][Full Text] [Related]
14. Case of pembrolizumab-induced myocarditis presenting as torsades de pointes with safe re-challenge.
Lee DH; Armanious M; Huang J; Jeong D; Druta M; Fradley MG
J Oncol Pharm Pract; 2020 Sep; 26(6):1544-1548. PubMed ID: 32089073
[TBL] [Abstract][Full Text] [Related]
15. Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab.
Tadokoro T; Keshino E; Makiyama A; Sasaguri T; Ohshima K; Katano H; Mohri M
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27650418
[No Abstract] [Full Text] [Related]
16. Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases.
Atallah-Yunes SA; Kadado AJ; Kaufman GP; Hernandez-Montfort J
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1527-1557. PubMed ID: 31028541
[TBL] [Abstract][Full Text] [Related]
17. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity.
Zarifa A; Lopez-Mattei J; Palaskas NL; Iliescu C; Durand JB; Kim PY
Adv Exp Med Biol; 2021; 1342():377-387. PubMed ID: 34972975
[TBL] [Abstract][Full Text] [Related]
18. Management of Immune-Related Endocrinopathies in Anticancer Treatment with Checkpoint Inhibitors.
Lakomý R; Poprach A; Kazda T
Klin Onkol; 2020; 33(1):15-19. PubMed ID: 32075383
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue.
Varricchi G; Marone G; Mercurio V; Galdiero MR; Bonaduce D; Tocchetti CG
Curr Med Chem; 2018; 25(11):1327-1339. PubMed ID: 28403786
[TBL] [Abstract][Full Text] [Related]
20. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
